This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
home:special:hospitals_emergencies [09.17.2017] – [If hospitalized] + telmisartan should never be taken by someone in a hospital setting, it will render the patient vulnerable to increased infection sallieq | home:special:hospitals_emergencies [09.17.2017] – [If hospitalized] sallieq | ||
---|---|---|---|
Line 93: | Line 93: | ||
* Patients on the MP should not take **nimesulide** (Aulin / Mesulid / Nimed). It could possibly cause internal bleeding. | * Patients on the MP should not take **nimesulide** (Aulin / Mesulid / Nimed). It could possibly cause internal bleeding. | ||
* rivaroxaban (Xarelto) increases the risk of bleeding and can cause serious or fatal bleeding. **A specific antidote for rivaroxaban is not available**. | * rivaroxaban (Xarelto) increases the risk of bleeding and can cause serious or fatal bleeding. **A specific antidote for rivaroxaban is not available**. | ||
- | * telmisartan should never be taken by someone in a hospital setting, it will render the patient vulnerable to increased | + | * telmisartan should never be taken by someone in a hospital setting, it will render the patient |
* Refuse all antifungals. Refuse all vitamin D supplementation in food, IV fluids or tube feedings. | * Refuse all antifungals. Refuse all vitamin D supplementation in food, IV fluids or tube feedings. | ||
* Alert staff to any other food allergies. | * Alert staff to any other food allergies. |